Previous studies have suggested that HSP90B1 is a promising candidate for cancer diagnosis and prognosis (63) and plays a role in regulating cisplatin sensitivity in bladder cancer (64). This evidence concerns the gene HSP90B1 and urinary bladder carcinoma.